TASK DEFINITION: In this task, you are given the abstract of a research paper. Your task is to generate a summary of this abstract. Your summary should not be very short, but it's better if it's not more than 30 words.
PROBLEM: For natural language understanding (NLU) technology to be maximally useful, it must be able to process language in a way that is not exclusive to a single task, genre, or dataset. In pursuit of this objective, we introduce the General Language Understanding Evaluation (GLUE) benchmark, a collection of tools for evaluating the performance of models across a diverse set of existing NLU tasks. By including tasks with limited training data, GLUE is designed to favor and encourage models that share general linguistic knowledge across tasks. GLUE also includes a hand-crafted diagnostic test suite that enables detailed linguistic analysis of models. We evaluate baselines based on current methods for transfer and representation learning and find that multi-task training on all tasks performs better than training a separate model per task. However, the low absolute performance of our best model indicates the need for improved general NLU systems.

SOLUTION: We present a multi-task benchmark and analysis platform for evaluating generalization in natural language understanding systems.

PROBLEM: We propose Adversarial Inductive Transfer Learning (AITL), a method for addressing discrepancies in input and output spaces between source and target domains. AITL utilizes adversarial domain adaptation and multi-task learning to address these discrepancies. Our motivating application is pharmacogenomics where the goal is to predict drug response in patients using their genomic information. The challenge is that clinical data (i.e. patients) with drug response outcome is very limited, creating a need for transfer learning to bridge the gap between large pre-clinical pharmacogenomics datasets (e.g. cancer cell lines) and clinical datasets. Discrepancies exist between 1) the genomic data of pre-clinical and clinical datasets (the input space), and 2) the different measures of the drug response (the output space). To the best of our knowledge, AITL is the first adversarial inductive transfer learning method to address both input and output discrepancies. Experimental results indicate that AITL outperforms state-of-the-art pharmacogenomics and transfer learning baselines and may guide precision oncology more accurately.

SOLUTION: A novel method of inductive transfer learning that employs adversarial learning and multi-task learning to address the discrepancy in input and output space

PROBLEM: Adam is shown not being able to converge to the optimal solution in certain cases. Researchers recently propose several algorithms to avoid the issue of non-convergence of Adam, but their efficiency turns out to be unsatisfactory in practice. In this paper, we provide a new insight into the non-convergence issue of Adam as well as other adaptive learning rate methods. We argue that there exists an inappropriate correlation between gradient $g_t$ and the second moment term $v_t$ in Adam ($t$ is the timestep), which results in that a large gradient is likely to have small step size while a small gradient may have a large step size. We demonstrate that such unbalanced step sizes are the fundamental cause of non-convergence of Adam, and we further prove that decorrelating $v_t$ and $g_t$ will lead to unbiased step size for each gradient, thus solving the non-convergence problem of Adam. Finally, we propose AdaShift, a novel adaptive learning rate method that decorrelates $v_t$ and $g_t$ by temporal shifting, i.e., using temporally shifted gradient $g_{t-n}$ to calculate $v_t$. The experiment results demonstrate that AdaShift is able to address the non-convergence issue of Adam, while still maintaining a competitive performance with Adam in terms of both training speed and generalization.

SOLUTION:
We analysis and solve the non-convergence issue of Adam.